Experience firsthand insights from company CEOs, secure direct access to high-quality investments and join a sophisticated network of successful investors.
Friday, 7th June 1pm (AEST)
Live Investor Briefing
Please join Plutonic Non-Executive Chairman Hedley Widdup for an investor briefing. In this session, Hedley will discuss why he thinks their flagship project could define a new mining district rivalling the biggest copper-gold projects in the world.
Speaker
Joseph Webb Executive Director
5th June 2026
5th March 2026
5th July 2026
29th May 2024
Joyned is an E-commerce technology company that is revolutionising how online purchases are made. Partnered with €31 B travel giant Amadeus, the business is rolling out its solution, targeting the $2.3 trillion-dollar global tourism industry.
DR Gerard Dyson
Managing Director – Spectur Limited (ASX: SP3)
John Forwood, CIO of Lowell Resources Fund, discusses his ‘blue-sky’ thesis for Plutonic and compares it to previous portfolio winners.
Hedley Widdup, CEO of leading resources fund manager Lion Selection Group (ASX:LSX), discusses why he believes that Plutonic represents a “once in a cycle” opportunity, elaborating on their progress and pathway to IPO.
Plutonic founder Dr Kris Butera discusses his flagship Champion project, expanding on why he believes there is potential for a resource deposit that is “unlike anything he has ever seen.”
25th March 2024
In this session Prescient CEO and Managing Director Steven Yatomi-Clarke provide a company update on strategy and upcoming milestones.
15th February 2024
In this session Wellnex Life MD Zack Bozinovski and Non-Executive Chairman Mario Tascone discussed what attracted Mario to Wellnex and where he sees the future of the business;
5th February 2026
5th May 2026
16th May 2024
In this session Felix Gold Executive Director Joseph Webb discussed their plans to develop a potential multi million ounce high grade gold resource.
DR Gerard Dyson Managing Director – Spectur Limited (ASX: SP3)
18th April 2024
In this session Far East Gold’s CEO and Director Shane Menere discussed the standout assays from our Woyla drilling campaigns that form the base of our upcoming maiden JORC resource publication.
9th April 2024
In this session Prescient CEO and Managing Director Steven Yatomi-Clarke discussed why the data from their PTX-100 Phase 1b trial is so promising.
14th March 2024
Join Stuart Roberts, co-founder and senior analyst at Pitt Street Research, for an online briefing where he will outline the recent Pitt Street Research report on Prescient Therapeutics.
22nd February 2024
In this session Far East Gold’s CEO and Director Shane Menere discussed, why the Board (including Nickel Industries MD Justin Werner) is optimistic about the findings so far……
14th February 2024
In this session VP Minerals (VPM) Non-Executive Director Graham Howard discussed VPM’s continued resource inventory targeting high grade critical mineral deposits.
In this session Propell CEO Michael Davidson discussed Propell’s recent progress on the platform, cost base, and establishing a broker network…
5th November 2026
7th November 2023
Propell (ASX: PHL) CEO Michael Davidson discusses how the company is successfully disrupting the banks with its innovative lending model, its exponential growth in its user base and revenues in the past year, and plans to take a significant portion of Australia’s $423 billion SME loan book.
13th August 2021
Professional Superannuation Management CEO Andrew Maloney discusses how the latest acquisition will put PSM on track to be one of the fastest-growing super funds in the country.
11th August 2021
Prescient Therapeutics (ASX: PTX) CEO and MD Steven Yatomi-Clarke discusses the encouraging progress through clinical trials of Prescient’s foundational assets PTX-100 and PTX-200.
5th August 2021
Wellnex Life (ASX: WNX) CEOGeorge Karafotias discusses how the company is well-placed to capture spend from the fast-growing global wellness market.
4th August 2021
This week we were joined by the CEOs of exciting ASX listed businesses: Prescient Therapeutics (ASX: PTX), Farm Pride Foods (ASX: FRM), WT Financial Group (ASX: WTL).
WT Financial Group Limited (ASX: WTL) is a diversified financial services company that contains two distinct channels: business-to-business and business-to-consumer.
Farm Pride Foods Ltd (ASX: FRM) is a grower, processor and marketer of eggs and egg based industrial products with continuous operations since 1937.
Prescient Therapeutics (ASX: PTX) is focused on developing novel, personalised therapies for a range of cancers.
26th July 2021
Reach Markets’ MD Patrick Nelson discusses an investment that may help you benefit from inflation, regardless if the market goes up or down.
21st July 2021
This week we were joined by the CEOs of exciting ASX listed businesses, who gave valuable insight to their industries and companies future prospects. Wellnex Life (ASX: WNX), Oar Resources (ASX: OAR), SECOS Group (ASX: SES).
SECOS Group Limited (ASX: SES) is a leading developer and manufacturer of sustainable packaging materials.
Oar Resources (ASX: OAR) is a precious metals explorer and aspiring producer.
Wellnex Life (ASX: WNX) is a specialist Australian brand and distribution company that is focused on consumer health & wellness products.
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.